Categories: News

First-in-Class Biologic Eye Drop Regener-Eyes(R) Announces Scholarship Winner

PALM HARBOR, FL / ACCESSWIRE / April 6, 2021 / Regener-Eyes® is pleased to announce Jenna Gardner as the recipient of the 2021 Academic Scholarship Program. After an overwhelmingly high response rate, the professionals at Regener-Eyes® feel that Jenna demonstrated both a passion for her area of study and a sophisticated understanding of regenerative medicine and its connection to eye health.

“We are proud to offer Jenna financial aid to help further her career in optometry,” stated C. Randall Harrell, M.D., CEO and Founder of Regener-Eyes®. “On behalf of the entire team, we wish her a successful academic year.”

Currently studying at the Kentucky College of Optometry, Jenna aims to gain further insight into the pharmacological aspects of eye care to better serve her local community.

In a 400-word essay, applicants were asked to explain how biologics are transforming regenerative medicine. Jenna explains how the active ingredients in Regener-Eyes® stimulate the body’s natural ability to heal:

“In the past, I often described dry eye treatments to act as band-aids only temporarily masking the problem. Now as I explore active ingredients in Regener-Eyes®, I understand how biologics could be better than tears in a variety of cases. Mimicking a normal, healthy tear film could increase the patient’s overall well-being by proactively treating before symptoms have a chance to manifest. For example, biologics containing cytokines closely associated with chronic eye inflammation that aid in cellular repair, would be invaluable for the vast number of glaucoma, diabetic retinopathy and macular edema patients. Just as hyaluronic acid would be for patients who need to hydrate the corneal surface.”

Jenna looks forward to continuing her studies as she discovers more ways to treat her community. Jenna will receive $10,000 US to be put towards her education. We captured Jenna’s reaction when she learned that she was selected as our top applicant.

The professionals at Regener-Eyes® would also like to formally thank all those who took the time to apply.

About Regener-Eyes®

Regener-Eyes® is a sterile biologic eye drop made of anti-inflammatory cytokines and growth factors. These types of proteins have been shown to reduce inflammation and stimulate the ocular surface to heal, repair, and regenerate. If you have patients that are not responding to current dry eye drugs, amniotic membrane intolerant, or having issues with blood serum tears, many physicians are finding success with Regener-Eyes® as a new option. For more information on our first in class biologic eye drop, please visit www.mydryeyes.org, follow us Instagram, like us on Facebook, watch us on YouTube and connect with us on LinkedIn.

For more information on the first-in-class biologic eye drop please visit the official site at www.mydryeyes.org.

Contact Information:

Regener-Eyes®, LLC
Heidi Hart Pukas
Heidi.pukas@regenerativeplant.org
http://regener-eyesscholarship.com/
https://www.linkedin.com/company/regener-eyes%C2%AE-llc
https://www.facebook.com/Mydryeyes

SOURCE: Regener-Eyes®

View source version on accesswire.com:
https://www.accesswire.com/639160/First-in-Class-Biologic-Eye-Drop-Regener-EyesR-Announces-Scholarship-Winner

Staff

Recent Posts

CardioComm Solutions Provides Update Respecting Debt Settlement

Toronto, Ontario--(Newsfile Corp. - July 8, 2024) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or…

2 hours ago

CONMED Corporation to Announce Second Quarter 2024 Financial Results on July 31, 2024

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced it will report financial results for the…

3 hours ago

AngioDynamics to Report Fiscal 2024 Fourth Quarter and Full-Year Financial Results on July 16, 2024

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on…

3 hours ago

Youth Inventors Compete at The Henry Ford during RTX Invention Convention U.S. Nationals June 5-7, 2024, in Dearborn, Michigan

DEARBORN, Mich., July 8, 2024 /PRNewswire/ -- The Henry Ford hosted over 435 youth inventors…

3 hours ago

Leading Medical Claims Management provider, Medlogix, LLC Announces the Acquisition of ReviewWorks

HAMILTON, N.J., July 8, 2024 /PRNewswire/ -- Medlogix, LLC, a leading, national medical claims management…

3 hours ago

Gymdesk Announces a $32.5 Million Strategic Growth Investment from Five Elms Capital

KANSAS CITY, Mo., July 8, 2024 /PRNewswire/ -- Gymdesk, a leading provider of member management…

3 hours ago